Fund Utilization Update: No Deviations Reported for Q1 FY27
Senores Pharmaceuticals Limited · SENORES · NSE ·
**No Deviation:** The company confirmed no deviation in the use of funds raised from its preferential issue for the quarter ended June 30, 2026. **Fund Source:** The update pertains to the utilization of ₹95 crore raised through a preferential issue of convertible equity warrants…